"MAC Clinical Research is a healthcare organisation dedicated to the development of new and improved treatments through clinical trials."

During the past decade, MAC Clinical Research, GAC House conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MAC Clinical Research, GAC House" are "Gastroparesis" (2 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "MAC Clinical Research, GAC House" in a lesser frequency.

Most popular intervention types in "MAC Clinical Research, GAC House" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Relamorelin" (1 trials) and "Relamorelin 10 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "MAC Clinical Research, GAC House" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MAC Clinical Research, GAC House". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MAC Clinical Research, GAC House, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MAC Clinical Research, GAC House, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".